Connection

Shikhar Mehrotra to Sirtuin 1

Back to Details
This is a "connection" page, showing publications Shikhar Mehrotra has written about Sirtuin 1.
Shikhar Mehrotra
Connection Strength
1.206
Sirtuin 1
  1. CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
    View in: PubMed
    Score: 0.705
  2. CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE. Trends Immunol. 2020 03; 41(3):187-189.
    View in: PubMed
    Score: 0.180
  3. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. Blood. 2019 01 17; 133(3):266-279.
    View in: PubMed
    Score: 0.166
  4. CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.